Target General Information
Target ID T86364
Target Name Vasoactive intestinal polypeptide receptor 1
Synonyms PACAP type II receptor; PACAP-R-2; Pituitary adenylate cyclase activating polypeptide type II receptor; VIP-R-1; VPAC-1; VPAC1; Vasoactive intestinal peptide receptor 1; Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor-1; VIPR1
Target Type Clinical Trial
Gene Name VIPR1
Biochemical Class GPCR secretin
UniProt ID VIPR1_HUMAN
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals
Disease Chronic obstructive pulmonary disease
Example drug Vasoactive intestinal peptide Phase 2 [522017], [1572592]
Tissue Lung tissue
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: -0.16
Z-score: -0.14
P-value: 6.47E-01
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Disease Chronic obstructive pulmonary disease
Example drug Vasoactive intestinal peptide Phase 2 [522017], [1572592]
Tissue Small airway epithelium
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: -0.12
Z-score: -0.26
P-value: 4.24E-01
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Target Gene Expression Profiles in Other Tissues of Healthy Individuals
Reference
Ref 522017ClinicalTrials.gov (NCT00464932) Vasoactive Intestinal Peptide in COPD. U.S. National Institutes of Health.
Ref 1572592NCBI GEO: archive for functional genomics data sets--update.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.